Clinical value of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions

Abstract

To explore the clinical value of contrast-enhanced ultrasound (CEUS) in differentiating benign and malignant focal liver lesions (FLLs) with SonoVue, CEUS was used to examine 113 patients with focal liver lesions (FLLs) in our hospital during July 2005 to December 2006. All the patients underwent contrast-enhanced CT (CECT) or contrast-enhanced MRI (CEMRI). Except for patients with focal fatty sparings (n=18) and with hemangiomas (n=8), all the patients were confirmed by operation or ultrasonic-guided liver puncture biopsy. A sulfur hexafluoride gas-based contrast agent was used with a MI of 0.15 to 0.17. Forty-eight cases of malignant FLLs, including 30 hepatocellular carcinomas (HCCs), 2 cholangiocarcinomas and 16 metastatic tumors, were detected. Seventy-eight cases of benign FLLs, including 33 hemangiomas, 9 focal nodular hyperplasias (FNHs), 19 focal fatty sparings, 5 abscesses, 7 regenerative nodules and 2 inflammatory pseudo-tumor, were involved. The contrast pattern of benign and malignant FLLs was quite different. CEUS has higher specificity and sensitivity than conventional ultrasound in differentiating benign and malignant FLLs.

Keywords

contrast-enhanced ultrasound / focal liver lesion / diagnosis / contrast agent

References

[1] AlexandeaV. H., ChristophV., ReinhardW., et al.. Real-time imaging with the sonographic contrast agent SonoVue. Radiology, 2004, 23: 1557-1568

[2] SchneiderM., ArditiM., BarrauM. B., et al.. BR1: a new ultrasonographic contrast agent based on sulphur hexafluoride-filled microbubbles. Invest Radiol, 1995, 30: 451-457

[3] SchneiderM.. SonoVue, a new ultrasound contrast agent. Eur Radiol, 1999, 9(suppl3): S347-S348

[4] HohmannJ., SkokJ., PulsR., et al.. Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue. Rofo, 2003, 75: 835-843

[5] YuX. L., DongB. W., LiangP.. Diagnosis of focal hepatic lesions with contrast-enhanced gray-scale ultrasonography with technique CPS and CCI. Chin J Medical Imaging Technol (Chinese), 2004, 20(7): 1080-1083

[6] LeenE., AngersonW. J., YarmenitisS., et al.. Multi-centre clinical stydy evaluating efficacy of sonovue: a new ultrasound contrast agent in Doppler investigation of focal hepatic lesiong. Eur J Radiology, 2002, 41(3): 200-206

[7] SolbiatiL., MarteganiA., LeenE., et al.. Contrast-enhanced ultrasound of liver diseases, 2003, Milan, Springer: 61-65

[8] ChenM. H.. Sonography for diseases of digestive tract, 2003, Beijing, Beijing Publishing House: 74-118

[9] ChenM. H., YanK., DdiY.. New gray scale contrast ultrasound technique in liver neoplasms diagnosis and radiofrequency ablation application. Chin J Medical Imaging Technol (Chinese), 2004, 20(3): 326-330

[10] ChenM. H., YanK.. The role of new contrast agent and contrast-enhanced gray-scale ultrasound in the diagnosis of liver neoplasms. Chin J Ultrason, 2004, 13(1): 38-42